Contraception

State regulations overruled to protect physicians’ clinical judgments.

Perrigo’s HRA Pharma has submitted an application to the US Food and Drug Administration (FDA) for possible future approval of the first-ever OTC birth control pill.

US President Joe Biden signed an executive order Friday protecting nationwide access to abortion and contraception.

As we were going to press with the July issue, the United States Supreme Court overturned Roe v Wade, eliminating the constitutional right to an abortion, and leaving the question of abortion rights to the states.

Bethany Corbin, Esq., sits down with Contemporary OB/GYN® to discuss the recent Supreme Court ruling overturning Roe v Wade and striking down almost 50 years of abortion precedent.

The United States Supreme Court voted to overturn Roe v Wade on Friday, eliminating the constitutional right to an abortion, and leaving the question of abortion rights to the states.

Interviews with mothers in the immediate postpartum period revealed that most decisions on breastfeeding and contraception were based on the personal experiences of participants and their friends and family.

Bassem Maximos, MD, MPH, FACOG, discusses 2 recent studies investigating nonhormomal contraceptive gel Phexxi (Evofem Biosciences) for the potential treatment of UTIs and improvement in sexual satisfaction.

A recent study presented at the 2022 American College of Obstetricians & Gynecologists' Annual Clinical & Scientific Meeting found that there was neither a decreased nor increased risk for postpartum depression in patients who received hormonal contraception due to insufficient evidence.

Elizabeth Ruzzo, PhD, discusses the findings of a report published by the UNFPA, which found women were abandoning effective methods of contraception due to misinformation.

Helen C. Wang, MD, shares key takeaways from the session she co-presented at PAS 2022.

TikTok user @midwifemama sparked a conversation about IUD insertion.

A cohort study in JAMA Pediatrics indicates that policies that increase access to immediate postpartum long-acting reversible contraception (LARC) improve birth outcomes.

Contraceptive effectiveness is determined by several factors, including drug or device efficacy, individual fecundability, coital frequency, and user adherence and continuation.

While the use of combined oral contraceptives (COCs) among patients with rheumatoid and autoimmune disorders have focused on safety, a narrative review in the Journal of Obstetrics and Gynaecology Research highlighted the efficacy and benefits of these contraceptives in females with rheumatoid arthritis (RA).

Combined oral contraceptives were found to be moderately more efficacious than placebo for treating overall premenstrual symptomatology in women with premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD).

Julie Harper, MD, of the Dermatology and Skin Care Center of Birmingham, Alabama explained the use, side effects, and risks of spironolactone and oral contraceptives in a presentation at the current Maui Derm for Dermatologists meeting in Maui, Hawaii.

Agile Therapeutics, Inc. recently announced a new alliance with Afaxys Pharma, LLC to promote levonorgestrel and ethinyl estradiol (Twirla) transdermal system.

Pooled estimates for chlamydia and/or gonorrhea were also null, but LARC users were significantly more likely to contract trichomoniasis infection compared to oral contraceptive users.

Half of prisons and over 80% of jails in the United States allowed postpartum permanent contraception, according to a study in the journal Contraception.

The findings support previous research demonstrating that increased access to emergency contraception does not compromise use of other more effective methods or lead to an increase in reported levels of unprotected sexual intercourse, according to Hawkins.

Often based on racial/ethnic, socioeconomic, and age-based assumptions

A new study found that reproductive history indicators were not directly linked to cognitive measures of Alzheimer’s disease (AD) in midlife women.

Patients in California were able to receive a contraceptive prescription during a visit with a pharmacist.

Professionals who provide contraception counseling need sufficient training and resources to offer comprehensive information about adverse reactions of intrauterine contraception, according to 2 web-based discussion boards about sexual and reproductive health.

A recent cohort study found an increase in unplanned pregnancies during the pandemic, as well as decreased access to contraception during this time.

For the analysis as a whole, “The more localized the copper on an IUD frame and the ability of the frame to conform to the uterine cavity, the more favorable were outcomes at one year,” wrote the authors.

One year after the close of the Increasing Access to Contraception (IAC) Learning Community, participants had sustained their efforts in support of at least 1 goal: to improve women’s access to the full range of contraceptive options.

A pair of studies provide insight into the increased risk of dysglycemia among women with PCOS and the potential influence of combined oral contraceptive pills on this risk in a population-based cohort.